Keywords: negative, trial, results, rock, immunex, enbrel, dropped

Negative trial results rock Immunex as Enbrel dropped for CHF

Article | 23 March 2001

Immunex has decided not to continue with its Phase II/III trials programfor Enbrel (etanercept) as a treatment for chronic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in